Changes in PIK3CA mutation status are not associated with recurrence, metastatic disease or progression in endocrine-treated breast cancer.
Breast cancer research and treatment 2014 Aug 147 (1): 211-9.
Arthur L M, Turnbull A K, Renshaw L, Keys J, Thomas J S, Wilson T R, Lackner M R, Sims A H, Dixon J
PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer.
Proceedings of the National Academy of Sciences of the United States of America 2010 Jun 107 (22): 10208-13.
Loi Sherene, Haibe-Kains Benjamin, Majjaj Samira, Lallemand Francoise, Durbecq Virginie, Larsimont Denis, Gonzalez-Angulo Ana M, Pusztai Lajos, Symmans W Fraser, Bardelli Alberto, Ellis Paul, Tutt Andrew N J, Gillett Cheryl E, Hennessy Bryan T, Mills Gordon B, Phillips Wayne A, Piccart Martine J, Speed Terence P, McArthur Grant A, Sotiriou Christ